See2cure Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$54.3K
- Investors
-
1
See2cure General Information
Description
Developer of a fluorescent diagnostic probe designed to detect secondary cancerous foci after injection into the patient the day before the procedure. The company's technology contributes to the prevention of relapses by preventing the reimplantation of tumor cells detached during surgery, enabling surgeons to identify microscopic tumor lesions and remove them completely.
Contact Information
Corporate Office
- Toulouse
- France
Corporate Office
- Toulouse
- France
See2cure Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Accelerator/Incubator | 12-Dec-2023 | $54.3K | Completed | Startup |
See2cure Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Nubbo | Accelerator/Incubator | Minority |
See2cure FAQs
-
Where is See2cure headquartered?
See2cure is headquartered in Toulouse, France.
-
What industry is See2cure in?
See2cure’s primary industry is Surgical Devices.
-
Is See2cure a private or public company?
See2cure is a Private company.
-
What is See2cure’s current revenue?
The current revenue for See2cure is
. -
How much funding has See2cure raised over time?
See2cure has raised $54.3K.
-
Who are See2cure’s investors?
Nubbo has invested in See2cure.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »